Studies related to Protection from Smoking and Benfotiamine

Benfotiamine Counteracts Smoking-induced Vascular Dysfunction In Healthy Smokers

Effect Increase
Trial Design Double blind
Trial Length 1-2 Weeks
Number of Subjects 20
Sex Both Genders
Age Range 18-29, 30-44
Body Types Average
Notes for this study:
The reduction in blood flow associated with acute smoking was halved with a 3-day preload of 1050mg Benfotiamine ,with some protective effects on inflammatory markers (sVCAM) but no alterations in blood pressure or heart rate.